Hans Minderman - Concepedia

Author

Hans Minderman

Roswell Park Comprehensive Cancer Center ORCID

Also Known As

H Minderman, H. Minderman, Hans Minderman, Minderman Hans

195

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

Roswell Park Comprehensive Cancer Center University at Buffalo, State University of New York Radboud University Nijmegen National Institutes of Health University of Pennsylvania

About

Hans Minderman is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	2.3K
2	Health Sciences	4	4	1.2K
3	Natural Sciences	3	3	113
4	Biochemistry	3	3	114
5	Engineering	2	2	98

Hans Minderman

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch, European Journal of Immunology Laboratory ImmunologyImmunologyPathologyImmunophenotypingImmune System	2019	965
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720 Maria R. Baer, Stephen L. George, Richard K. Dodge, Blood	2002	365
Cyclosporin A Is a Broad-Spectrum Multidrug Resistance Modulator Misbah Qadir, Kieran L. O’Loughlin, Stacy M. Fricke, Clinical Cancer Research	2005	237
Peroxiredoxin 1 Stimulates Secretion of Proinflammatory Cytokines by Binding to TLR4 Jonah Riddell, Xiangyang Wang, Hans Minderman, The Journal of Immunology	2009	205
Purity and yield of melanoma exosomes are dependent on isolation method Shin La Shu, Yunchen Yang, Cheryl Allen, Journal of Extracellular Vesicles Isolation MethodImmunocytochemical TechniqueImmunologyExtracellular MicrovesiclesDermatology	2019	181
NADPH Oxidase Limits Innate Immune Responses in the Lungs in Mice Brahm H. Segal, Wei Han, Jennifer J. Bushey, PLoS ONE	2010	179
VX-710 (Biricodar) Increases Drug Retention and Enhances Chemosensitivity in Resistant Cells Overexpressing P-Glycoprotein, Multidrug Resistance Protein, and Breast Cancer Resistance Protein Hans Minderman, Kieran L. O’Loughlin, Lakshmi Pendyala, Clinical Cancer Research	2004	169
Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment Shin La Shu, Yunchen Yang, Cheryl Allen, Scientific Reports	2018	167
Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s Takaaki Oba, Mark D. Long, Tibor Keler, Nature Communications	2020	126
Quantifying nuclear p65 as a parameter for NF‐κB activation: Correlation between ImageStream cytometry, microscopy, and Western blot Orla Maguire, Christine Collins, Kieran L. O’Loughlin, Cytometry Part A	2011	121

Page 1